Abstract:The passivation and selective activation strategies for the sonodynamic and NIR imaging performances of NIR sonosensitizers are reported. An intelligent antitumor theranostic platform termed Cu‐IR783 is facilely constructed. The tumor‐specific released Cu ions realize the cascade amplification of ROS generation and triggeres cuproptosis. ICD effects are induced by enhanced ROS levels and cuproptosis, which promote robust systemic immune responses. Reactive oxygen species (ROS)‐mediated sonodynamic therapy (SDT) holds increasing potential in treating deep‐seated tumor owing to the high tissue‐penetration depth. However, the inevitable accumulation of sonosensitizers in normal tissues not only make it difficult to realize the in situ SDT, but also induces sonodynamic effects in normal tissues. Herein, this work reports the passivation and selective activation strategies for the sonodynamic and near‐infrared (NIR) imaging performances of an intelligent antitumor theranostic platform termed Cu‐IR783 nanoparticles (NPs). Owing to the ruptured coordination bond between IR783 with Cu ions by responding to tumor microenvironment (TME), the selective activation of IR783 only occurred in tumor tissues to achieve the visualized in‐situ SDT. The tumor‐specific released Cu ions not only realized the cascade amplification of ROS generation through Cu+‐mediated Fenton‐like reaction, but also triggered cuproptosis through Cu+‐induced DLAT oligomerization and mitochondrial dysfunction. More importantly, the immunosuppressive TME can be reversed by the greatly enhanced ROS levels and high‐efficiency cuproptosis, ultimately inducing immunogenic cell death that promotes robust systemic immune responses for the eradication of primary tumors and suppression of distant tumors. This work provides a distinct paradigm of the integration of SDT, CDT, and cuproptosis in a controlled manner to achieve visualized in‐situ antitumor therapy.

IR-780 Dye as a Sonosensitizer for Sonodynamic Therapy of Breast Tumor

Ir-780 Dye Can Be Used As A Sonodynamic Agent Against Breast Tumor

Conjugated Oligo (phenylene Vinylene) Covalently Linked Porphyrin for Sonodynamic Therapy

An Ultrasound‐Excitable Aggregation‐Induced Emission Dye for Enhanced Sonodynamic Therapy of Tumors

Water-Soluble Iridic-Porphyrin Complex for Non-invasive Sonodynamic and Sono-oxidation Therapy of Deep Tumors.

Exploring BODIPY derivatives as sonosensitizers for anticancer sonodynamic therapy

Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer

Sonodynamic Therapy for HER2+ Breast Cancer with Iodinated Heptamethine Cyanine–Trastuzumab Conjugate

NIR‐II Ratiometric Fluorescent Nanoplatform for Real‐Time Monitoring and Evaluating Cancer Sonodynamic Therapy Efficacy

Ultrasound-triggered release of sinoporphyrin sodium from liposome-microbubble complexes and its enhanced sonodynamic toxicity in breast cancer

Mitochondria-targeted High-Load Sound-Sensitive Micelles for Sonodynamic Therapy to Treat Triple-Negative Breast Cancer and Inhibit Metastasis.

Tumor Microenvironment Activated Cu Crosslinked Near‐Infrared Sonosensitizers for Visualized Cuproptosis‐Enhanced Sonodynamic Cancer Immunotherapy

Bifunctional Nano‐Assembly of Iridium(III) Phthalocyanine Complex Encapsulated with BSA: Hypoxia‐relieving/Sonosensitizing Effects and Their Immunogenic Sonodynamic Therapy

Nanosonosensitization by Using Copper–Cysteamine Nanoparticles Augmented Sonodynamic Cancer Treatment

Nanosonosensitizers With Ultrasound-Induced Reactive Oxygen Species Generation for Cancer Sonodynamic Immunotherapy

Multifunctional sonosensitizers in sonodynamic cancer therapy.

Ultrasound Sonosensitizers for Tumor Sonodynamic Therapy and Imaging: A New Direction with Clinical Translation

Using C-doped TiO2 Nanoparticles as a Novel Sonosensitizer for Cancer Treatment

Ultrasound Activated Probe for Disease Imaging and Therapy In-Vivo

In Situ Conversion of Rose Bengal Microbubbles into Nanoparticles for Ultrasound Imaging Guided Sonodynamic Therapy with Enhanced Antitumor Efficacy.

Red blood cell membrane-enveloped O<sub>2</sub> self-supplementing biomimetic nanoparticles for tumor imaging-guided enhanced sonodynamic therapy